- Home
- APLT vs OLO Comparison
APLT vs OLO Comparison
Compare APLT & OLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- OLO
- Stock Information
- Founded
- APLT 2016
- OLO 2005
- Country
- APLT United States
- OLO United States
- Employees
- APLT N/A
- OLO N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- OLO Major Banks
- Sector
- APLT Health Care
- OLO Finance
- Exchange
- APLT Nasdaq
- OLO Nasdaq
- Market Cap
- APLT 971.6M
- OLO 818.6M
- IPO Year
- APLT 2019
- OLO 2021
- Fundamental
- Price
- APLT $8.69
- OLO $6.43
- Analyst Decision
- APLT Strong Buy
- OLO Strong Buy
- Analyst Count
- APLT 5
- OLO 3
- Target Price
- APLT $12.50
- OLO $8.33
- AVG Volume (30 Days)
- APLT 1.8M
- OLO 1.6M
- Earning Date
- APLT 11-07-2024
- OLO 11-07-2024
- Dividend Yield
- APLT N/A
- OLO N/A
- EPS Growth
- APLT N/A
- OLO N/A
- EPS
- APLT N/A
- OLO N/A
- Revenue
- APLT N/A
- OLO $271,872,000.00
- Revenue This Year
- APLT N/A
- OLO $24.04
- Revenue Next Year
- APLT $3,169.03
- OLO $15.37
- P/E Ratio
- APLT N/A
- OLO N/A
- Revenue Growth
- APLT N/A
- OLO 26.41
- 52 Week Low
- APLT $1.79
- OLO $4.20
- 52 Week High
- APLT $10.62
- OLO $7.13
- Technical
- Relative Strength Index (RSI)
- APLT 46.34
- OLO 70.69
- Support Level
- APLT $9.44
- OLO $5.39
- Resistance Level
- APLT $10.62
- OLO $7.13
- Average True Range (ATR)
- APLT 0.62
- OLO 0.34
- MACD
- APLT -0.13
- OLO 0.14
- Stochastic Oscillator
- APLT 14.95
- OLO 67.73
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About OLO Olo Inc.
Olo Inc is an open Software as a Service platform for restaurants. Its platform powers restaurant brands' on-demand digital commerce operations, enabling digital ordering, delivery, front-of-house management, and payments, while further strengthening and enhancing restaurants' direct guest relationships. The company generates revenue from providing its customers access to its platform.